Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1573399817666210806114200 http://scihub22266oqcxt.onion/10.2174/1573399817666210806114200 34365928!ä!34365928 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Diabetes+Rev 2022 ; 18 (3): e060821195364 Nephropedia Template TP {{tp|p=34365928|t=2022. Covid 19 May Limit the Use of Anti-hyperglycemic Agents Does it Call for the Development of New Anti-hyperglycemic Agents?|pdf=|usr=}}{{34365928}} gab.com Text Covid 19 May Limit the Use of Anti-hyperglycemic Agents Does it Call for the Development of New Anti-hyperglycemic Agents JO: Curr Diabetes Rev http://www.kidney.de/pget.php?&tw=1&pmid=34365928 #FOAvip Diabetes mellitus has been identified as a major risk factor for developing severe COVID 19 complications. In this review article, the efforts were directed to provide insights and the possible extent to which some diabetic pharmacological interventions may exacerbate COVID 19 or may not be idyllic options for COVID 19 patients. Articles reviewed were identified using the Google scholar database, and search was done using the English language. Anti-hyperglycemic is associated with undesirable effects including episodes of hypoglycemia, diarrhea, lactic acidosis, and increased risks of cardiovascular and hepatic hazards. These undesirable effects associated with the anti-hyperglycemic agents possess a threat of developing severe COVID19 complications Therefore, this calls for more studies to understand the extent of the risks these agents possess in diabetic COVID 19 patients. Almost all the anti-hyperglycemic agents have the potential to worsen COVID 19, despite their class. COVID 19 may limit the options in terms of available anti-hyperglycemic agents which may not heighten the risk of developing severe COVID 19 complications. The research towards the discovery and development of new compounds and also new therapeutic targets for hyperglycemia should be encouraged and welcome. Twit Text FOAVip Covid 19 May Limit the Use of Anti-hyperglycemic Agents Does it Call for the Development of New Anti-hyperglycemic Agents ????Curr Diabetes Rev http://www.kidney.de/pget.php?&tw=1&pmid=34365928 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34365928 #FOAvip English Wikipedia <ref>{{Cite pmid|34365928}}</ref> Covid 19 May Limit the Use of Anti-hyperglycemic Agents Does it Call for the Development of New Anti-hyperglycemic Agents? #MMPMID34365928 Sibiya N; Mbatha B; Arineitwe C; Onyekwuluje C; Ngubane P; Khathi A Curr Diabetes Rev 2022[]; 18 (3): e060821195364 PMID34365928show ga Diabetes mellitus has been identified as a major risk factor for developing severe COVID 19 complications. In this review article, the efforts were directed to provide insights and the possible extent to which some diabetic pharmacological interventions may exacerbate COVID 19 or may not be idyllic options for COVID 19 patients. Articles reviewed were identified using the Google scholar database, and search was done using the English language. Anti-hyperglycemic is associated with undesirable effects including episodes of hypoglycemia, diarrhea, lactic acidosis, and increased risks of cardiovascular and hepatic hazards. These undesirable effects associated with the anti-hyperglycemic agents possess a threat of developing severe COVID19 complications Therefore, this calls for more studies to understand the extent of the risks these agents possess in diabetic COVID 19 patients. Almost all the anti-hyperglycemic agents have the potential to worsen COVID 19, despite their class. COVID 19 may limit the options in terms of available anti-hyperglycemic agents which may not heighten the risk of developing severe COVID 19 complications. The research towards the discovery and development of new compounds and also new therapeutic targets for hyperglycemia should be encouraged and welcome. |*Acidosis, Lactic/chemically induced[MESH] |*COVID-19 Drug Treatment[MESH] |*COVID-19/complications[MESH] |*Diabetes Mellitus[MESH] |*Hypoglycemia/chemically induced[MESH] |Humans[MESH]Covid 19 May Limit the Use of Anti-hyperglycemic Agents Does it Call (epmc).pdf DeepDyve Pubget Overpricing